Yonghe Medical Group Co. Ltd. has released its Annual Report for the year 2024. The report highlights the company's strategic shift from "scale expansion" to "quality development" in the hair-related healthcare industry. The Group has emphasized technological innovation and a standardized approach to improving quality and patient satisfaction. It continues to optimize its single-store model and deepen penetration into the women's market while strengthening its chain operation capabilities. The Group's industry-leading operational capabilities have enabled effective cost control, operational efficiency, and improved profitability. Yonghe Medical Group collaborates with Class IIIA hospitals and academic institutions to enhance its diagnostic, therapeutic, and R&D capabilities. The company is also actively promoting and adopting new technologies to propel business development. The full report can be accessed through the link below.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。